Search by job, company or skills
Hospitals/Healthcare/Diagnostics
Department - Commercial - GBS
Are you passionate about taking your competitive intelligence journey to next level Do you want to provide insights on digital health (DH), beyond drug/device intelligence. Do you want to work for a globally renowned organization Novo Nordisk We are seeking a Sr. Global Competitive Intelligence Manager to join our vibrant and fast-moving Com-mercial-GBS team in Bangalore, India. If that sounds like you, read on and apply today for a life-changing career.
The position
As a Sr. Global Competitive Intelligence Manager at Novo Nordisk, you will be responsible to:
Provide technical and scientific intelligence using data-driven assessments on Digital Health (DH) for therapy areas in Novo Nordisk and markets for competi-tors and partners.
Deliver competitive overview of DH focusing on connected drug delivery devices and solutions such as drug-device combinations, diagnostic AI solutions, support-ive / add-on solutions, digital biomarkers, disease monitoring solutions, disease management solutions, Software as a Medical Device (SaMD), digital therapeutics (DTx) and analysis of key market factors & technological trends.
Drive process to establish an overview of near-, medium- and long-term chal-lenges and opportunities posed to Novo Nordisk. Drive quarterly updates of Com-petition Monitors. Update internal CI reporting platforms like SharePoint, Monthly newsletters. Deliver regular updates with implications for the company, therapy area, portfolio or the market by identifying new trends, market events, assess landscapes, un-met needs etc. Deliver ad-hoc deep-dives on select themes, in-cluding partner scans and technology landscapes.
Continuous track digital health activities, pharma, big-tech and med-tech initia-tives, health tech investments, real-world or clinical evidence data from DH initia-tives or from relevant partnerships across the ecosystem.
Ensure timely monitoring, analysis, and communication of all relevant competitor activities to the stakeholders.
Qualifications
We are looking for candidates with the following qualifications:
Master's degree in Life Sciences, Medicine or Pharmaceutical Sciences.
6+ years of working experience in the Competitive Intelligence industry focusing on the pharmaceutical or medical device industry.
Independently perform daily tasks without supervision. Keep-up-to date with in-dustry and therapy area knowledge and adapt swiftly.
Good understanding of relevant aspects for the development and marketing of drugs, devices, data, and digital solutions, including:
Digital health, device and diagnostic understanding, Drug landscape know-how, Technology insight, Disease understanding, Market understanding, Clinical and Regulatory knowledge, ability to understand the interplay and potential upcoming combinations of Digital Health, Drug, Diagnostic, Data, and Devices.
Significant experience in professionally communicating scientific, technological, and commercial information to audiences at various organisational levels.
Excellent communication skill with strategic mindset and analytical approach.
About the department
The Commercial - GBS unit is responsible for driving deliverables for multiple Corporate Vice President (CVP) areas within Commercial - GBS. This includes Insulin, GLP-1 and Obesity Marketing, Market Access, Insights, and Commercial Operations. Located in Bangalore, India, our team is dynamic and fast-paced, working together to make a dif-ference in the lives of patients worldwide.
Working at Novo Nordisk
Novo Nordisk is a leading global healthcare company with a 100-year legacy of driving change to defeat serious chronic diseases. Building on our strong legacy within diabetes, we are growing massively and expanding our commitment, reaching millions around the world and impacting more than 40 million patient lives daily. All of this has made us one of the 20 most valuable companies in the world by market cap. Our success relies on the joint potential and collaboration of our more than 63,000 employees around the world. We recognise the importance of the unique skills and perspectives our people bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk, we're working toward something bigger than ourselves, and it's a collective effort. Join us! Together, we go further. Together, we're life changing.
Contact
To submit your application, please upload your CV online (click on Apply and follow the instructions).
Apply Now!
Deadline
4th December, 2024
Disclaimer
It has been brought to our attention that there have recently been instances of fraudulent job offers, purporting to be from Novo Nordisk and/or its affiliate companies. The individuals or organizations sending these false employment offers may pose as a Novo Nordisk recruiter or representative and request personal information, purchasing of equipment or funds to further the recruitment process or offer paid trainings. Be advised that Novo Nordisk does not extend unsolicited employment offers. Furthermore, Novo Nordisk does not charge prospective employees with fees or make requests for funding as a part of the recruitment process.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we're life changing.
Login to check your skill match score
Date Posted: 27/11/2024
Job ID: 101631357
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries, and affiliates or offices in 5 countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a supermajority (45%) of its voting shares.